Vitamin and Mineral Deficiencies on Tirzepatide: Which Nutrients Run Low, and How to Stay Ahead of Them

Tirzepatide works largely by helping people eat less, and in the SURMOUNT-1 trial participants on the highest dose lost an average of about 21 percent of their body weight over 72 weeks, much of it through a sustained reduction in daily food intake. The less discussed consequence of that smaller plate is that it also carries a smaller supply of vitamins and minerals, while the body's need for those nutrients does not shrink at the same rate.

Over a year or longer, the difference between intake and requirement can widen enough to appear on blood work, and this article explains which nutrients tend to run low on tirzepatide, what current research shows, and how people on treatment can work with their clinician to stay ahead of it.

Does tirzepatide cause vitamin deficiencies?

Tirzepatide does not directly cause vitamin deficiencies, but it can make them more likely by reducing how much food a person eats. Tirzepatide activates GIP and GLP-1 receptors, which slows gastric emptying and reduces appetite, and every meal that is shrunk or skipped removes the vitamins and minerals it would have supplied.

Food aversions add to that risk, because the foods people most often drop, such as red meat and large salads, tend to be the best sources of iron, B12 and folate, while nausea, vomiting and diarrhea can reduce intake further. Many people also begin treatment with borderline levels, since vitamin D insufficiency is more common at higher body weight, partly because vitamin D is stored in fat tissue.

Which nutrients are most likely to run low on tirzepatide?

The nutrients most likely to run low on tirzepatide are vitamin D, iron, vitamin B12, thiamine, calcium, magnesium and potassium. Published research on GLP-1 users points most consistently to vitamin D, followed by iron and the B vitamins, with mineral shortfalls also observed.

Vitamin D. Vitamin D deficiency is the most frequently recorded nutritional deficiency in GLP-1 users, appearing in about one in seven patients after a year of treatment in the largest dataset. Vitamin D supports calcium absorption and bone mineralization, which matters more during weight loss because substantial weight reduction is associated with some loss of bone density, and low levels may also contribute to muscle weakness.

Iron. Iron is concentrated in red meat, shellfish, legumes and fortified grains, several of which often become less appealing during treatment, and women who menstruate carry the highest baseline risk. Low iron typically produces fatigue, breathlessness and hair shedding, which are easy to blame on the medication itself.

Vitamin B12 and folate. Vitamin B12 comes almost entirely from animal foods, so people who drift toward a lighter, more plant based diet on tirzepatide can see levels fall over time. The risk is higher for anyone also taking metformin or a proton pump inhibitor, since both are well documented to reduce B12 absorption, and a prolonged deficiency can cause tingling in the hands and feet, memory problems and anemia.

Thiamine. Thiamine deficiency is uncommon on tirzepatide, but it deserves attention because the body stores only a few weeks of supply. Persistent vomiting combined with very low intake can deplete those stores, and a small number of published case reports describe Wernicke encephalopathy, which causes confusion, unsteady walking and eye movement problems, in people on GLP-1 medications who had prolonged vomiting.

Calcium, magnesium and potassium. Intake of these minerals often falls because dairy, leafy greens, beans, nuts and fruit are eaten in smaller amounts. Low magnesium and potassium may contribute to muscle cramps and palpitations, and diarrhea or vomiting increases losses of both.

How long does it take for deficiencies to develop on tirzepatide?

Nutrient deficiencies on tirzepatide usually take months to develop rather than weeks, which is consistent with the research finding more diagnoses at 12 months than at 6 months. The timeline depends on how large the body's reserve is for each nutrient, as the figure below illustrates.

Thiamine and electrolytes can drop within weeks when vomiting or diarrhea are significant, whereas iron and vitamin D usually decline over several months, and a B12 deficiency from diet alone tends to appear only after years unless metformin or acid suppressing medications are also involved.

What are the warning signs of a deficiency on tirzepatide?

The most common warning signs are fatigue that persists after the dose escalation period, ongoing hair shedding, brittle nails, muscle cramps, pale skin and tingling in the hands or feet. Because several of these overlap with ordinary early side effects of the medication, timing is often the most useful clue. Fatigue in the first four to eight weeks is usually linked to lower calorie intake and fluid shifts, while fatigue that persists after several months on a stable dose is a reasonable prompt for lab work. Similarly, some hair shedding three to six months after rapid weight loss is common, but shedding well beyond that window may point to low iron, zinc or protein.

Which labs are worth discussing while taking tirzepatide?

The labs most often discussed during tirzepatide treatment are a complete blood count, ferritin, vitamin B12, 25-hydroxyvitamin D and a basic metabolic panel that includes electrolytes. A baseline panel before starting and a repeat every 6 to 12 months is a common framework, which a clinician may tighten to every three to six months during active weight loss for people at higher risk. Higher risk groups include people with prior bariatric surgery, women with heavy periods, people taking metformin or proton pump inhibitors, vegetarians and vegans, adults over 60, and anyone with persistent digestive side effects.

Should people on tirzepatide take a multivitamin?

Many people on tirzepatide may benefit from a daily multivitamin, particularly when total food intake is well below their usual diet. The 2025 joint advisory on nutritional priorities for GLP-1 therapy, issued by the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association and The Obesity Society, recommends a food first approach and notes that a multivitamin can help fill gaps when intake is reduced.

A multivitamin provides a floor rather than a correction, however, and it will not resolve an established iron or vitamin D deficiency, which usually requires targeted dosing guided by lab values. High dose single supplements carry their own risks, since iron can worsen the constipation that is already common on tirzepatide and excess vitamin D can raise blood calcium.

What should people eat on tirzepatide to avoid deficiencies?

The most protective eating pattern on tirzepatide places the most nutrient dense foods first on a smaller plate. When appetite is limited, starting a meal with protein and colorful vegetables and leaving refined starches for last makes it more likely that the most valuable foods are eaten before fullness arrives. Eggs, Greek yogurt and fish supply protein, B12, calcium and vitamin D in small portions, lean meats and shellfish provide absorbable iron and zinc, and beans, lentils and leafy greens contribute folate, magnesium and potassium.

Vitamin D is the hardest of these nutrients to obtain from a reduced diet, because few foods contain meaningful amounts, as the comparison below shows.

Protein deserves its own priority alongside micronutrients. Clinical guidance for people on GLP-1 medications commonly suggests roughly 1.0 to 1.5 grams of protein per kilogram of goal or adjusted body weight per day, which also supports lean muscle during weight loss and tends to bring iron, zinc and B12 along with it.

Are some people on tirzepatide at higher risk of deficiencies?

Some people on tirzepatide start with smaller reserves or have additional reasons for reduced absorption, which raises their risk. People with prior bariatric surgery warrant particular attention, because procedures such as gastric bypass already reduce absorption of iron, B12, calcium and vitamin D, and adding tirzepatide lowers intake further, so an existing supplement plan should be reviewed with the prescriber when treatment begins. Adults over 60 face a related problem, since appetite and stomach acid production often decline with age, which reduces B12 absorption and leaves older adults more vulnerable to the bone and muscle effects of low vitamin D and calcium.

The bottom line

The reduced appetite that drives weight loss on tirzepatide is also what makes nutrient gaps more likely over time, and research on GLP-1 users suggests that deficiencies, led by vitamin D, become more common between 6 and 12 months of treatment. These gaps are largely predictable, which means a protein forward, nutrient dense eating pattern, a basic multivitamin when intake is low, and periodic lab checks with a clinician give most people a practical way to protect their energy, hair, bones and nerves while treatment continues. Anyone who cannot keep food or fluids down for more than a day or two should contact their prescriber promptly.